Atlas Trials

An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)

Clinical trial NCT02997176 · COMPLETED

Trial details

NCT number
NCT02997176
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2016-09-30
Primary completion
2020-02-12
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.